Thomas Kosasa Acquires 1,449,275 Shares of OneMedNet (NASDAQ:ONMD) Stock

OneMedNet Corporation (NASDAQ:ONMD) Director Thomas Kosasa acquired 1,449,275 shares of the firm’s stock in a transaction dated Thursday, July 30th. The stock was bought at an average cost of $0.69 per share, with a total value of $999,999.75. Following the acquisition, the director owned 18,538,150 shares in the company, valued at approximately $12,791,323.50. This trade represents a 8.48% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Thomas Kosasa also recently made the following trade(s):

• On Friday, June 12th, Thomas Kosasa bought 158,730 shares of OneMedNet stock. The shares were bought at an average cost of $0.63 per share, for a total transaction of $99,999.90.
• On Monday, May 18th, Thomas Kosasa bought 268,817 shares of OneMedNet stock. The shares were bought at an average cost of $0.93 per share, for a total transaction of $249,999.81.

OneMedNet Trading Down 4.3%

Shares of ONMD stock opened at $0.62 on Friday. OneMedNet Corporation has a twelve month low of $0.44 and a twelve month high of $4.22. The stock has a market cap of $35.57 million, a P/E ratio of -12.49 and a beta of 1.14. The stock has a 50 day moving average of $0.67 and a 200 day moving average of $0.78.

OneMedNet (NASDAQ:ONMD) last released its quarterly earnings data on Friday, May 15th. The company reported ($0.04) EPS for the quarter. The business had revenue of $0.10 million during the quarter.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the stock. Wall Street Zen downgraded shares of OneMedNet from a “hold” rating to a “sell” rating in a report on Saturday, May 23rd. Weiss Ratings reiterated a “sell (e+)” rating on shares of OneMedNet in a research report on Monday, June 1st. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company has an average rating of “Sell”.

Institutional Trading of OneMedNet

Institutional investors and hedge funds have recently made changes to their positions in the business. Exencial Wealth Advisors LLC raised its stake in shares of OneMedNet by 1.3% during the 4th quarter. Exencial Wealth Advisors LLC now owns 3,644,861 shares of the company’s stock worth $4,009,000 after buying an additional 45,401 shares during the period. State Street Corp grew its stake in OneMedNet by 41.5% in the 4th quarter. State Street Corp now owns 116,700 shares of the company’s stock valued at $128,000 after acquiring an additional 34,200 shares during the period. Jane Street Group LLC purchased a new stake in OneMedNet in the 4th quarter worth $119,000. Virtu Financial LLC purchased a new stake in OneMedNet in the 4th quarter worth $48,000. Finally, HRT Financial LP acquired a new position in OneMedNet during the fourth quarter worth $32,000. 0.95% of the stock is currently owned by hedge funds and other institutional investors.

OneMedNet Company Profile

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.